2018台灣生技月 Bio Taiwan 生物科技大展

2018 台灣生技月 南港展覽館

PROGRAM

Greater China & Asia-Pacific Opportunities Conference

Organizer:Taiwan Bio Industry Organization
DateJune 30, 9:00~18:00
VenueRoom 401, TWTC Nangang Exhibition Hall (No. 1, Jingmao 2nd. Rd., Nangang Dist., Taipei City)
LanguageEnglish & Chinese (with simultaneous translation to English)

08:30 – 09:00

Registration

09:00 – 09:05

Opening RemarksJohnsee Lee, Taiwan Bio Industry Organization
Session Chair:  Monica He, Director, International Affairs , Biotechnology Innovation Organization (BIO)

09:05 – 09:45

Entry Strategies for Selected ASEAN Healthcare Markets
Radhika Nayak , Director, PwC South East Asia Consulting Healthcare Strategy Lead, PwC

09:45 – 10:25

Current Status of ASEAN Pharma Industry
Yu-Chen Hsu, Director, Development Center for Biotechnology

10:25 – 10:40

Coffee Break

10:40 – 11:20

Accelerate Business Development in China's Dynamic Biopharma Industry
Donglin Huang, Chief Consultant, Healthcare Synergy & Strategy

11:20– 12:00

The Successful Finance & Tax Strategy to Invest Life Science & Healthcare Sector in ASEAN Countries
Cheli Liaw, International Tax Partner, Deloitte & Touche

12:00 – 13:30

Lunch Break

13:30 – 14:00

Introduction to Biomedicinal Product and Drug Registration in Vietnam 
Thao Thi Do, Head of the Laboratory Institute of Biotechnology, VAST
                     Invited Expert for Vaccine and Biomedical Product Evaluation, Drug Administrative

                     Office, Vietnam Ministry of Health

14:00 – 14:40 Opportunity and Challenges of Drug Development in ASEAN : A Regulatory Perspective
Lucky Slamet, Independent Consultant, and Adviser of BPOM(National Drug and Food Control Agency), Indonesia

14:40 – 15:00

Building ASEAN Drug Development Strategies – From Pharma's Perspective 
Fang Hsin Lee, President, Y.S.P. Southease Asia Holding Berhad 

15:00 – 16:00

Building ASEAN Drug Development Strategies – From Diagnostic's Perspective 
TC Lin, Chairman & CEO, General Biologicals Corporation

Nathan Tirtana, Director, PT UBC Medical, Indonesia

16:00 – 16:15

Coffee Break

16:15 – 16:45

Road to Biologics: From an ASEAN Pharmaceutical Perspective
Ker Yin Lee, CEO, Etana Biotech

16:45 – 17:45

Panel Discussion
Moderator: Monica He, Director, International Affairs , BIO
Panelists
Lucky Slamet, Independent Consultant, Indonesia
Fang Hsin Lee, President, Y.S.P. Southeast Asia Holding Berhad
TC Lin, Chairman & CEO, General Biologicals Corporation
Nathan Tirtana, Director, PT UBC Medical Indonesia
Ker Yin Lee, CEO, Etana Biotech